GENERAL30 Sept 2026
Iranians face soaring medicine prices as US blockade, sanctions hit hard
Medicines are getting dearer and harder to find in Iran. A US port blockade since June and tight sanctions have squeezed the drug industry, which depends on imported raw materials. Some medicines now cost over three times more, food prices have jumped, and the currency has lost half its value. If you buy or ship medicines from that region, check supply and payment routes early.
Key Statutory Highlights
- Some medicines in Iran have more than tripled in price after an American naval blockade cut off sea shipping.
- Iran produces over 80% of its medicines domestically, but many of those rely on imported raw materials.
- US sanctions do not directly target medicines, yet banks and companies often refuse to process such payments.
Actionable Advice for Taxpayers / Founders:If your business imports medicines or pharmaceutical raw materials from that region, review your supply and payment routes now, and speak to a trade or customs advisor before confirming new orders.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: